Biological importance of structurally diversified chromenes
Compounds incorporating the chromene scaffold are largely present in natural products and
display a wide variety of biological activities. Their low toxicity combined to the broad …
display a wide variety of biological activities. Their low toxicity combined to the broad …
Current developments of coumarin compounds in medicinal chemistry
XM Peng, G LV Damu, H Zhou - Current pharmaceutical …, 2013 - ingentaconnect.com
Coumarin compounds represent an important type of naturally occurring and synthetic
oxygen-containing heterocycles with typical benzopyrone framework. This type of special …
oxygen-containing heterocycles with typical benzopyrone framework. This type of special …
Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins
A Maresca, C Temperini, L Pochet… - Journal of medicinal …, 2010 - ACS Publications
Coumarin derivatives were recently shown to constitute a totally new class of inhibitors of the
zinc metalloenzyme carbonic anhydrase (CA, EC 4.2. 1.1), being hydrolyzed within the CA …
zinc metalloenzyme carbonic anhydrase (CA, EC 4.2. 1.1), being hydrolyzed within the CA …
Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment
G Stoll, C Kleinschnitz… - Blood, The Journal of the …, 2008 - ashpublications.org
In ischemic stroke, treatment options are limited. Therapeutic thrombolysis is restricted to the
first few hours after stroke, and the utility of current platelet aggregation inhibitors, including …
first few hours after stroke, and the utility of current platelet aggregation inhibitors, including …
The antithrombotic activity of natural and synthetic coumarins
Thrombosis, which seriously endangers human health and life, is the leading cause of
morbidity and mortality globally. Antithrombotic drugs can interfere with the occurrence and …
morbidity and mortality globally. Antithrombotic drugs can interfere with the occurrence and …
[HTML][HTML] Synthetic coumarin derivatives with anticoagulation and antiplatelet aggregation inhibitory effects
Thrombosis is the leading cause of illness and mortality worldwide, posing a serious risk to
human health and life. Because antithrombotic drugs can prevent the beginning and …
human health and life. Because antithrombotic drugs can prevent the beginning and …
Factor XII/XIIa inhibitors: Their discovery, development, and potential indications
Coagulation factor XII (FXII), a S1A serine protease, was discovered more than fifty years
ago. However, its in vivo functions and its three-dimensional structure started to be disclosed …
ago. However, its in vivo functions and its three-dimensional structure started to be disclosed …
Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins
F Chimenti, D Secci, A Bolasco… - Journal of medicinal …, 2009 - ACS Publications
A large series of 3-carboxamido-7-substituted coumarins have been synthesized and tested
in vitro for their human monoamine oxidase A and B (hMAO-A and hMAO-B) inhibitory …
in vitro for their human monoamine oxidase A and B (hMAO-A and hMAO-B) inhibitory …
Factor XI and XII as antithrombotic targets
F Müller, D Gailani, T Renne - Current opinion in hematology, 2011 - journals.lww.com
Hereditary deficiency of factor XII (Hageman factor) or factor XI, plasma proteases that
initiate the intrinsic pathway of coagulation, impairs thrombus formation and provides …
initiate the intrinsic pathway of coagulation, impairs thrombus formation and provides …
[PDF][PDF] A Multicomponent Coupling Reaction Induced by Insertion of Arynes into the C O Bond of Formamide
E Yoshioka, S Kohtani, H Miyabe - … Chemie International Edition, 2011 - academia.edu
Aryne compounds are highly reactive intermediates that have been widely used in organic
synthesis.[1, 2] In recent years, studies on aryne-based reactions have achieved some …
synthesis.[1, 2] In recent years, studies on aryne-based reactions have achieved some …